Trial Profile
A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight Aspirin-Treated Subjects With Stable Coronary Artery Disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Aspirin; Clopidogrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms FEATHER
- Sponsors Eli Lilly and Company
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
- 27 Mar 2012 Results presented at the 61st Annual Scientific Session of the American College of Cardiology.
- 10 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.